• Print
Cervical screening in Australia 2013–2014
Cervical screening in Australia 2013–2014 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Around 57% of women in the target age group of 20–69 took part in the program, with more than 3.8 million women screening in 2013 and 2014.Cervical cancer incidence for women of all ages remains at an historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
Cervical screening in Australia 2012–2013
Cervical screening in Australia 2012–2013 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Around 58% of women in the target age group of 20–69 took part in the program, with more than 3.8 million women screened in 2012 and 2013.Cervical cancer incidence for women of all ages remains at an historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
National cervical cancer prevention data dictionary version 1: working paper
The National Cervical Screening Program aims to reduce incidence, morbidity and mortality from cervical cancer in Australia. The National cervical cancer prevention data dictionary is an assemblage of data elements used by the National Cervical Screening Program, developed by the Australian Institute of Health and Welfare in partnership with state and territory and Commonwealth components of the National Cervical Screening Program to support its aim of achieving national consistency in data reporting through promoting standardisation and comparability of data across the jurisdictions.
Cervical screening in Australia 2011-2012
Cervical screening in Australia 2011-2012 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Around 58% of women in the target age group of 20-69 took part in the program, with more than 3.7 million women screening in 2011 and 2012.Cervical cancer incidence for women of all ages remains at a historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
Report on monitoring activities of the National Cervical Screening Program Safety Monitoring Committee
This report looks at the evidence collected and assessed by the Safety Monitoring Committee established to assess whether there were adverse outcomes following the introduction of new NHMRC guidelines on how women with a low-grade Pap test result or a treated high-grade cervical biopsy result should be managed. Acknowledging that new evidence may come to light in future which could affect this picture, the overarching message from the evidence currently available and the methods used to assess this evidence is that the new guidelines have not led to an increase in cervical cancer in the seven years since they were introduced.
Cervical screening in Australia 2010-2011
Cervical screening in Australia 2010-2011 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Around 57% of women in the target age group of 20-69 took part in the program, with more than 3.6 million women screened in 2010 and 2011. Cervical cancer incidence in this age group remains at a historical low of 9 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
Cervical screening in Australia 2009-2010
 Cervical screening in Australia 2009-2010 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer.About 57% of women in the target age group of 20-69 took part in the program, with more than 3.6 million women screened in 2009 and 2010. Cervical cancer incidence in this age group remains at a historical low of 9 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
Cervical screening in Australia 2008-2009
The National Cervical Screening Program aims to reduce incidence, morbidity and mortality from cervical cancer. Cervical screening in Australia 2008-2009 presents national statistics monitoring the NCSP using new performance indicators.  For women in the target age group, 20-69 years, participation in the program was around 59%, with more than 3.6 million women screened over the 2 years 2008-2009. Cervical cancer incidence remains at an historical low of 9 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.
Cervical screening in Australia 2007-2008
This data report uses the previous definition of performance indicators, and supplies up-to-date data, but with no commentary. A full report using the new definitions of the performance indicators (for 2008-2009) will follow.
Cervical screening in Australia 2006-2007
The major objective of the National Cervical Screening Program is to reduce incidence and mortality from cervical cancer. Over 3.5 million women (61.5%) aged 20-69 years participated in the Program in 2006-2007, up from the last report. Incidence and mortality remain low at 9 new cases in 2005 and 2 deaths in 2006 per 100,000 women aged 20-69 years.
Cervical screening in Australia 2005-2006
The major objective of the National Cervical Screening Program is to reduce morbidity and mortality from cervical cancer by maximising early detection.Cervical screening in Australia 2005-2006 is the tenth annual report on key program activity, performance and outcome indicators to monitor the achievements of the National Cervical Screening Program. The report provides a comprehensive national picture of cervical screening in Australia for 2005-2006. The report presents the most recent information on participation in cervical screening, rate of early re-screening, low- and high-grade abnormalities detected, and incidence and mortality of cervical cancer. Where possible, data are presented by state and territory stratification as well as nationally.This report will be relevant to anyone with an interest in women's health or cervical screening, including health planners and administrators, various health practitioners, academic researchers and the general public.
Cervical screening in Australia 2004-2005
Cervical screening in Australia 2004-2005 is the ninth annual report on key program activity, performance and outcome indicators to monitor the achievements of the National Cervical Screening Program. The report provides a comprehensive national picture of cervical screening in Australia for 2004-2005. The report presents most recent information on participation in cervical screening, rate of early re-screening, low-grade and high-grade abnormalities detected, incidence of cervical cancer and morality. Analyses of incidence and mortality data by location (major cities, regional and remote) as well as mortality by Indigenous status are also presented. Where possible, data are presented by state and territory stratification. The report will be relevant to anyone with an interest in women's health or cervical screening, including health planners and administrators, various health practitioners, academic researchers and the general public.
Cervical screening in Australia 2003-2004
This is the eighth national report monitoring the performance of the National Cervical Screening Program using ten indicators which measure program activity, performance and outcome. These indicators help measure changes in disease patterns and examine the contribution of cervical screening to preventing or reducing deaths from cancer of the cervix. It differs from previous reports that were exclusively published on the internet in that it is limited to presenting data from the Programs in table format and does not include the usual descriptive text and graphs.
Rural, regional and remote health: mortality trends 1992-2003
This report compares changes in mortality in Australia's major cities, regional and remote areas in the period 1992-2003. Trends for Australia's broad geographic regions are compared for a range of specific causes of death including coronary heart disease, lung cancer, cervical cancer, asthma, suicide, motor vehicle traffic accidents, diabetes and many others.
Cervical screening in Australia 2002-2003
The report presents most recent information on participation in cervical screening, rate of early re-screening, low-grade and high-grade abnormalities detected, incidence of cervical cancer and mortality. Analyses of incidence and mortality data by location (major cities, regional and remote) as well as mortality by Indigenous status are also presented. Where possible, data are presented by state and territory stratification.
Cervical screening in Australia 2001-02
This report is the sixth national report on the performance of the National Cervical Screening Program in Australia. Cervical screening services are provided as part of mainstream health services with general practitioners performing approximately 80% of Pap smears. The program is funded by the Australian Government, and the state and territory governments.This report presents statistics on the performance monitoring indicators agreed to by the National Advisory Committee to the program.
Cervical screening in Australia 2000-2001 and 1999-2000
This is the third annual report based on key program activity, performance and outcome indicators to monitor the achievements of the National Cervical Screening Program. The report provides a comprehensive national picture of cervical screening in Australia for 2000-2001 and 1999-2000. The report presents most recent information on participation in cervical screening, rate of early rescreening, low-grade and high-grade abnormalities detected, incidence of cervical cancer and mortality. Analysis of incidence and mortality data by location (rural, remote and metropolitan) as well as mortality by Indigenous status are also presented. Where possible, data are presented by state and territory stratification.
Cervical screening in Australia 1999-2000
Cervical Screening in Australia 1999-2000 provides a comprehensive national picture of cervical screening in Australia for the two-year period 1999-2000, based on key program activity, performance and outcome indicators.The report presents the most recent information on participation in cervical screening, the rates of early re-screening, detection of low-grade and high-grade abnormalities, and cervical cancer incidence and mortality. It includes analyses of incidence and mortality by location (rural, remote and metropolitan) as well as mortality by Indigenous status. Where possible, data are presented by State and Territory as well as for Australia as a whole.Cervical Screening in Australia 1999-2000 is the fourth annual report of the National Cervical Screening Program.
Cervical screening in Australia 1998-1999
This report provides a comprehensive national picture of cervical screening in Australia for 1998-1999. It presents most recent information on participation in cervical screening, rate of early re-screening, low-grade and high-grade abnormalities detected, incidence of cervical cancer and mortality. Analysis of incidence and mortality data by location (rural, remote and metropolitan) as well as mortality by Indigenous status are also presented.
Cervical screening in Australia 1997-1998
The National Cervical Screening Program has developed a set of key performance and outcome indicators to monitor Program achievements. This publication is the second annual report of the Program and presents data and analysis for 1997-1998. The report includes three new periodic indicators that broaden its scope and add substantially to the information available on cervical cancer screening in Australia. These are incidence and mortality by location (rural, remote, metropolitan) and mortality by Indigenous status. Where possible, State and Territory comparisons are also provided.
Breast and cervical cancer screening in Australia 1996-1997
This report is the first to present national data on breast and cervical cancer screening in Australia. It presents data based on a new set of indicators for breast and cervical cancer screening from BreastScreen Australia and the National Cervical Screening Program. Data on current status, trends over time, and State and Territory comparisons are also provided wherever possible. Breast and cervical cancer screening in Australia 1996-1997 is a joint project between the AIHW, the Commonwealth Department of Health and Aged Care, BreastScreen Australia and the National Cervical Screening Program. It is a valuable addition to the AIHW's Cancer Series.
Cervical cancer in Australia
Cervical Cancer in Australia brings together research findings, previously published data and new information to describe the patterns of cervical cancer in Australia.
Issues in cervical cancer screening and treatment: new technologies and costs of alternative management strategies
This report has been prepared at the request of the National Task Force on Cervical Cancer Screening to assist in the development of national programs for screening and follow-up treatment.
Cost study on management protocols for women with abnormal pap smears
This report was prepared for the National Taskforce for the Prevention of Cancer of the Cervix, and to assist the NHMRC Working Party on the Management of Women with Abnormalities Detected in Cervical Cancer Screening. Costs have been prepared from the perspective of government as the financing authority, and do not include costs to women participating in the program.
Issues of cervical cancer screening and treatment: New technologies and costs of alternative management strategies
This report has been prepared at the request of the National Task Force on Cervical Cancer Screening to assist in the development of national programs for screening and follow-up treatment.

Pages: First Previous Page 1 of 2 Next Last